Hummingbird bioscience

Index
Globenewswire

Hummingbird Bioscience Announces First Patient Dosed in Phase II Trial of HMBD-001 and Cetuximab in Advanced Squamous Cell Cancers

Globenewswire

Hummingbird Bioscience Appoints Dr. James Garner as President

Globenewswire

Hummingbird Bioscience Wins APAC Trailblazer Award at 2026 Nebius AI Discovery Awards

Globenewswire

Hummingbird Bioscience Announces First Patient Dosed in Phase I Clinical Trial of HMBD-501 in Advanced HER3-Expressing Solid Malignancies

Globenewswire

Hummingbird Bioscience Licenses HMBD-002, Phase II-Ready Anti-VISTA Monoclonal Antibody to Percheron Therapeutics

Globenewswire

Hummingbird Bioscience Licenses Novel Antibodies to Immunome

Globenewswire

Hummingbird Bioscience Announces Poster Presentation on HMBD-802, Novel Dual-Payload Antibody-Drug Conjugate, at EORTC-NCI-AACR 2024

Globenewswire

Hummingbird Bioscience Announces Key Leadership Appointments

Globenewswire

Hummingbird Bioscience Presents New Preclinical Data Highlighting Next-Generation Antibody-Drug Conjugate Capabilities at PEGS Boston 2024